GL1X · GenesisL1 explorer

MolNFT v1 · #112884 · protein

Human gar transformylase in complex with gar and N-{4-[4-(2-amino-4- oxo-4,7-dihydro-3H-PYRROLO[2,3-D]PYRIMIDIN-6-YL)BENZYL]BENZOYL}-L- glutamic acid (AGF23)

4ZYT · Trifunctional purine biosynthetic protein adenosine-3: “Human gar transformylase in complex with gar and N-{4-[4-(2-amino-4…”. X-ray diffraction, 2 ligands (GAR, 3Y9), 1 pocket (best druggability 0.66). MolNFT v1 #112884 on…

PDB
4ZYT
Type
protein
Length
200 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Trifunctional purine biosynthetic protein adenosine-3
EC
2.1.2.2
UniProt
P22102
Ligands
GAR, 3Y9
Pockets
1 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATrifunctional purine biosynthetic protein adenosine-3 (EC 2.1.2.2)protein20037% helix, 24% strandP22102

Ligands and binding sites

  • GAR · Glycinamide ribonucleotide · ligand · chains A
  • 3Y9 · N-{4-[4-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)butyl]benzoyl}-L-glutamic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12950.660.8238GAR, 3Y9

Compared structures

  • 4ZYT · Human GAR transformylase in complex with GAR and… · the same entry in another collection · chain A against A, TM-score 1.00
  • P22102 · AlphaFold monomer V2.0 prediction for trifunctional purine biosynthetic protein… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.